Following the release of aquaculture biotech group Benchmark's disappointing earnings for the first quarter of 2020, revealing that the company is deep in the red, the company's shareholders appeared to be shaken, reflected in a share price that fell nearly 10 percent as the market opened today.
Benchmark's market capitalization dropped from £255 million (€299 million/$328 million) to £230 million (€269 million/$296 million), shaving off £25 million (€29 million/$32 million) from the company's value in just one day.
